Parametric Portfolio Associates’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Parametric Portfolio Associates’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$478K	Sell	3,767 -1,949	-34%	-$219K	﹤0.01%	3115
2021 Q4	$749K	Sell	5,716 -379	-6%	-$49K	﹤0.01%	2904
2021 Q3	$746K	Buy	6,095 +430	+8%	+$49.6K	﹤0.01%	2930
2021 Q2	$646K	Sell	5,665 -139	-2%	-$16.2K	﹤0.01%	2978
2021 Q1	$698K	Buy	5,804 +2,535	+78%	+$287K	﹤0.01%	3330
2020 Q4	$332K	Buy	+3,269	New	+$303K	﹤0.01%	3553
2020 Q3	–	Sell	-10,178	Closed	-$1.13M	–	3983
2020 Q2	$1.13M	Sell	10,178 -2,016	-17%	-$175K	﹤0.01%	2850
2020 Q1	$878K	Sell	12,194 -2,877	-19%	-$246K	﹤0.01%	2874
2019 Q4	$1.14M	Buy	+15,071	New	+$660K	﹤0.01%	3003

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Parametric Portfolio Associates's KRTX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Karuna Therapeutics, Inc. Common Stock (KRTX) stake by 34% in Q1 2022, selling an estimated $219K and leaving 3,767 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #3115.

Parametric Portfolio Associates first reported a position in KRTX in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.14M in Q4 2019. 177 funds tracked by Wall St. Rank hold KRTX as of Q1 2022.

Parametric Portfolio Associates held 3,767 shares of Karuna Therapeutics, Inc. Common Stock worth $478K as of Q1 2022.
Parametric Portfolio Associates sold 1,949 Karuna Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $219K.
Karuna Therapeutics, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3115 holding.
Parametric Portfolio Associates first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and has held it in 9 quarters since.
Parametric Portfolio Associates's Karuna Therapeutics, Inc. Common Stock position peaked at $1.14M in Q4 2019.
177 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.